Skip to content

IOVA

IOVANCE BIOTHERAPEUTICS, INC.

NASDAQ · Healthcare · Biotechnology · US

$10.25
+2.30%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+145.1%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 10, 2026BILINSKY IGOR · officer: Chief Operating OfficerM-Exempt7,813$0.00
Sep 10, 2026Puri Raj K. · officer: Chief Regulatory OfficerM-Exempt9,766$0.00
Sep 10, 2026Vogt Frederick G · director, officer: Interim CEO & General CounselM-Exempt15,626$0.00
Sep 10, 2026Vogt Frederick G · director, officer: Interim CEO & General CounselF-InKind6,638$8.70
Sep 10, 2026BILINSKY IGOR · officer: Chief Operating OfficerF-InKind3,976$8.70
Sep 10, 2026Puri Raj K. · officer: Chief Regulatory OfficerF-InKind4,478$8.70
Sep 3, 2026BILINSKY IGOR · officer: Chief Operating OfficerM-Exempt8,789$0.00
Sep 3, 2026Puri Raj K. · officer: Chief Regulatory OfficerM-Exempt5,470$0.00
Sep 3, 2026Vogt Frederick G · director, officer: Interim CEO & General CounselM-Exempt41,669$0.00
Sep 3, 2026Vogt Frederick G · director, officer: Interim CEO & General CounselF-InKind17,702$8.28
Sep 3, 2026BILINSKY IGOR · officer: Chief Operating OfficerF-InKind4,472$8.28
Sep 3, 2026Puri Raj K. · officer: Chief Regulatory OfficerF-InKind2,508$8.28
Aug 12, 2026Kirby Daniel Gordon · officer: Chief Commercial OfficerM-Exempt10,001$0.00
Aug 12, 2026Kirby Daniel Gordon · officer: Chief Commercial OfficerF-InKind2,436$6.40
Aug 10, 2026Roche Corleen M. · officer: Chief Financial OfficerF-InKind21,238$6.21
Aug 10, 2026Roche Corleen M. · officer: Chief Financial OfficerM-Exempt49,995$0.00
Jun 18, 2026Countouriotis Athena · directorA-Award90,316$0.00
Jun 18, 2026WEISER MICHAEL · directorA-Award90,316$0.00
Jun 18, 2026Puri Raj K. · officer: Chief Regulatory OfficerA-Award15,000$0.00
Jun 18, 2026Maynard Ryan D · directorA-Award90,316$0.00
Jun 18, 2026Dukes Iain D. · directorA-Award180,632$0.00
Jun 9, 2026Vogt Frederick G · director, officer: Interim CEO & General CounselM-Exempt15,625$0.00
Jun 9, 2026Puri Raj K. · officer: Chief Regulatory OfficerF-InKind3,843$4.23
Jun 9, 2026BILINSKY IGOR · officer: Chief Operating OfficerM-Exempt7,813$0.00
Jun 9, 2026GRAF FINCKENSTEIN FRIEDRICH · officer: Chief Medical OfficerM-Exempt7,813$0.00
Jun 9, 2026Vogt Frederick G · director, officer: Interim CEO & General CounselF-InKind6,638$4.23
Jun 9, 2026Puri Raj K. · officer: Chief Regulatory OfficerM-Exempt9,766$0.00
Jun 9, 2026GRAF FINCKENSTEIN FRIEDRICH · officer: Chief Medical OfficerF-InKind3,976$4.23
Jun 9, 2026BILINSKY IGOR · officer: Chief Operating OfficerF-InKind3,976$4.23
Jun 3, 2026BILINSKY IGOR · officer: Chief Operating OfficerM-Exempt8,790$0.00
Institutional positioning

13F filings over the trailing two quarters

New 111Increased 251Reduced 127Sold out 37
FilerActionSharesFiled
BlackRock, Inc.Increased36,957,681Aug 7, 2026
BLACKROCK, INC.Increased31,080,505May 13, 2026
MHR FUND MANAGEMENT LLCUnchanged28,967,103Aug 14, 2026
MHR FUND MANAGEMENT LLCUnchanged28,967,103May 15, 2026
STATE STREET CORPIncreased24,478,268Aug 7, 2026
TWO SIGMA INVESTMENTS, LPIncreased19,010,697Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased18,204,248Aug 13, 2026
STATE STREET CORPReduced17,448,108May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position16,617,737May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased14,388,999Aug 13, 2026
TWO SIGMA INVESTMENTS, LPIncreased13,687,433May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position11,700,844May 8, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased10,324,826Aug 12, 2026
MILLENNIUM MANAGEMENT LLCIncreased9,414,292May 15, 2026
GOLDMAN SACHS GROUP INCReduced8,760,060May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 10, 2026